GRAIL, Inc.

GRAL
$59.98 (- $6.57 - 9.87%)
Last updated: 2026-06-06 09:26 UTC
GRAL Metrics
Exchange
🇺🇸 NASDAQ XNGS
Nasdaq/NGS (Global Select Market)United StatesAmerica/New_York
SectorHealthcare
IndustryDiagnostics & Research
ISINUS3847471014
CUSIP384747101
Market Price59.98
Dividend Yield N/A
Dividend Growth
1YN/A
3YN/A
5YN/A
10YN/A
Annual Dividend N/A
Latest Payout ($)N/A
Latest Payout DateN/A
Dividend FrequencyNone
P/E RatioN/A
EPS-10.66
Market Cap$3.6B
Book Value61.94
Price to Book1.483
BetaN/A
52w High115.76
52w Low16.56
Next Earnings DateN/A

GRAIL, Inc. trades under ticker GRAL on NASDAQ as a stock. Use this page to review stock price, dividends, and price history. The page also shows Healthcare exposure. Identifiers: ISIN US3847471014, CUSIP 384747101.

About the Company
GRAIL, Inc., a commercial-stage healthcare company, provides multi-cancer early detection testing and services in the United States and internationally. It offers Galleri, a cancer screening test for asymptomatic individuals over 50 years of age; and DAC, a diagnostic aid for cancer tests to accelerate diagnostic resolution for patients for whom there is a clinical suspicion of cancer. The company also provides development services, including support for ongoing clinical studies, pilot testing, research, and therapy development. In addition, it develops minimal residual disease post-diagnostic tests. The company was incorporated in 2015 and is headquartered in Menlo Park, California.
Price History